Which patient is at MOST risk for developing Digoxin toxicity?

Prepare for your NCLEX exam focusing on heart failure. Utilize questions with explanations and hints to ensure exam readiness. Empower your study sessions with effective strategies and guidance for success.

Multiple Choice

Which patient is at MOST risk for developing Digoxin toxicity?

Explanation:
Digoxin has a very narrow therapeutic window, and its toxicity risk rises when electrolytes are imbalanced, especially magnesium. Low magnesium levels potentiate digoxin’s effect on the Na+/K+-ATPase pump, leading to more intracellular calcium, increased electrical instability, and a higher chance of dangerous arrhythmias. An older patient already has greater susceptibility due to age-related changes in clearance, but the critical factor here is hypomagnesemia (magnesium 1 mg/dL). The other scenarios show normal potassium and calcium levels (and a non-direct risk from hyperglycemia), so they’re less likely to tip into toxicity. Hence, the patient with the low magnesium level is most at risk.

Digoxin has a very narrow therapeutic window, and its toxicity risk rises when electrolytes are imbalanced, especially magnesium. Low magnesium levels potentiate digoxin’s effect on the Na+/K+-ATPase pump, leading to more intracellular calcium, increased electrical instability, and a higher chance of dangerous arrhythmias. An older patient already has greater susceptibility due to age-related changes in clearance, but the critical factor here is hypomagnesemia (magnesium 1 mg/dL). The other scenarios show normal potassium and calcium levels (and a non-direct risk from hyperglycemia), so they’re less likely to tip into toxicity. Hence, the patient with the low magnesium level is most at risk.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy